Turning Point downgraded by JMP Securities
$TPTX
Biotechnology: Pharmaceutical Preparations
Health Care
JMP Securities downgraded Turning Point from Market Outperform to Market Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/20/2022 | $58.00 | Buy | BofA Securities |
| 3/1/2022 | $50.00 → $45.00 | Hold | Stifel |
| 2/10/2022 | $120.00 → $85.00 | Overweight | Wells Fargo |
| 1/21/2022 | $115.00 → $105.00 | Outperform | Oppenheimer |
| 12/7/2021 | Outperform | Cowen & Co. | |
| 11/10/2021 | $150.00 → $115.00 | Outperform | Oppenheimer |
| 10/12/2021 | $178.00 → $162.00 | Buy | HC Wainwright & Co. |
| 10/11/2021 | Market Outperform → Market Perform | JMP Securities |